Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

著者: Johan Maertens, Issam Raad, Kieren A. Marr, Thomas F. Patterson, Dimitrios P. Kontoyiannis, Oliver A. Cornely, Eric J. Bow, Galia Rahav, Dionysios Neofytos, Mickaël Aoun, John W. Baddley, Michael Giladi, Werner Heinz, Raoul Herbrecht, William Hope, Meinolf Karthaus, Dong‐Gun Lee, Olivier Lortholary, Vicki A. Morrison, Ilana Oren, Dominik Selleslag, Shmuel Shoham, George R. Thompson, Misun Lee, Rochelle Maher, Anne‐Hortense Schmitt‐Hoffmann, Bernhardt Zeiher, Andrew J. Ullmann - The Lancet 2015 被引用: 972